Combined treatment with intravitreal bevacizumab and laser photocoagulation for exudative maculopathy in facioscapulohumeral muscular dystrophy

ABSTRACT Purpose: To report a rare case of exudative maculopathy in a patient with facioscapulohumeral muscular dystrophy (FSHD), and its management. Methods: Observational case report. Results: A 62-year-old man with genetically confirmed FSHD was referred to our department complaining of decreased visual acuity in his left eye. At presentation, right eye examination was unremarkable and best-corrected visual acuity (BCVA) was 20/20. Left eye BCVA was 20/100 and it presented a dense cataract with the evidence of macular lipid exudation. Cataract surgery combined with intravitreal bevacizumab improved BCVA to 20/20. Postoperative fundus examination disclosed focal macular retinal microvascular dilations with lipid exudation inferotemporal to the fovea. Fluorescein angiography highlighted these macular telangiectatic abnormalities but no peripheral lesions were detected. Spectral domain optical coherence tomography (SD-OCT) showed mild temporal retinal thickening, sparing the fovea. A diagnosis of exudative maculopathy due to macular telangiectasia secondary to FSHD was established. One year later, his left eye vision dropped to 20/32 and macular SD-OCT showed an aggravation of the intraretinal fluid and exudation. He was then submitted to a second intravitreal injection of bevacizumab followed by one angio-guided focal laser photocoagulation session, with a significant improvement. Twelve months later, his BCVA remained 20/20 on both eyes with no recurrence of exudation. Conclusion: The present work shows that in cases of visual-threatening macular exudation, intravitreal anti-vascular endothelial growth factor injections combined with focal laser photocoagulation may be a safe and effective treatment. This article also highlights that all FSHD patients should be screened for asymptomatic retinal vascular disorders.

[1]  S. Karceski.  Diagnosis and treatment of facioscapulohumeral muscular dystrophy , 2015, Neurology.

[2]  J. Duker,et al.  Retinal telangiectasis detected during a vision screening examination in a child with hearing loss led to the diagnosis of facioscapulohumeral muscular dystrophy. , 2014, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[3]  Daniel G. Miller,et al.  Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells. , 2013, Human molecular genetics.

[4]  J. Statland,et al.  Coats syndrome in facioscapulohumeral dystrophy type 1 , 2013, Neurology.

[5]  C. Shields,et al.  Coats-like retinopathy in an infant with preclinical facioscapulohumeral dystrophy. , 2012, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[6]  R. Fitzsimons.  Retinal vascular disease and the pathogenesis of facioscapulohumeral muscular dystrophy. A signalling message from Wnt? , 2011, Neuromuscular Disorders.

[7]  J. Pulido,et al.  Coats’ disease associated with muscular dystrophy treated with ranibizumab , 2010, Eye.

[8]  R. Wuebbles,et al.  FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy , 2009, Disease Models & Mechanisms.

[9]  C. Shields,et al.  Neovascular glaucoma from advanced Coats disease as the initial manifestation of facioscapulohumeral dystrophy in a 2-year-old child. , 2007, Archives of ophthalmology.

[10]  Jin-Kwan Han,et al.  Xenopus Dab2 is required for embryonic angiogenesis , 2006, BMC Developmental Biology.

[11]  L. Bindoff,et al.  Severe fascioscapulohumeral muscular dystrophy presenting with Coats’ disease and mental retardation , 2006, Neuromuscular Disorders.

[12]  J E Hewitt,et al.  FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. , 1993, Human molecular genetics.

[13]  A. Bird,et al.  Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. , 1987, Brain : a journal of neurology.

[14]  J. Kepes,et al.  Inflammatory facioscapulohumeral muscular dystrophy and coats syndrome , 1982, Annals of neurology.

[15]  M. Brooke,et al.  Facioscapulohumeral dystrophy associated with hearing loss and coats syndrome , 1982, Annals of neurology.

[16]  A. Bird,et al.  Severe visual loss associated with retinal telangiectasis and facioscapulohumeral muscular dystrophy , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[17]  J. J. Grote,et al.  On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy , 1995, Muscle & nerve. Supplement.